The FICO Data Privacy Policy explains FICO’s collection and use of cookies. Cookies help us remember your settings to provide you with a better browsing experience; allow us to assess, monitor, and improve the website’s performance; and enable our partners to advertise to you. You may disable the cookies by changing the settings in your browser, and you may tell us not to share your cookie data with third parties. By using this website, you consent to the use of cookies as described in the FICO Data Privacy Policy.
Medication adherence is closely linked with clinical outcomes. As reported by the Center for Disease Control (CDC), one half of US patients stop taking their medications within one year of being prescribed. The FICO® Medication Adherence Score identifies patients at risk for non-compliance so the chain of healthcare providers can proactively take actions to improve adherence levels through interaction and better decisions on treatment design. Not a retrospective of what happed and what should have happened that places healthcare providers in a reactive mode, but an intelligent analysis and prediction of future risk of non-adherence.
By identifying each patient’s propensity toward medication adherence over the next 12 months, this fully HIPAA-compliant solution helps direct activities to patients at highest risk of noncompliance, improving program efficiency and maximizing results.
Effectively identify medication non-compliance Using the same world-class predictive methodologies used to create the FICO® Score, expertise from delivering a wide range of healthcare analytics and leveraging multiple, third-party data sources, the FICO® Medication Adherence Score can predict each patient’s adherence over the next year. Tailored to the desired performance measurement, the Medication Adherence Score can inform pharmaceutical manufacturers, healthcare payers and the lifeline of medical professionals overseeing a patients’ progress through a drug regiment.
Take a proactive approach to compliance management While other methodologies identify lapses in patient medication adherence only after the fact, the FICO® Medication Adherence Score is a predictive model that allows you to identify and proactively address adherence problems before they occur. Integrate with your patient communications systems for tailored dialogues, reminders, alerts and improved message targeting and timing.
Improve program planning and targeting Gauge the right level of action across the patient base to optimize care, case management and drug utilization programs—setting a universal baseline assessment. on which survey results or other patient information can be overlaid when available. Develop refined intervention and adherence programs through ‘test & learn’ strategies. Execute through FICO® CCS in a single, integrated, automated solution that optimizes multiple communications channels.
The FICO® Medication Adherence Score can be executed through the FICO® Decision Management Suite (DMS). The decision platform provides a simple, cost-effective way to develop and deploy analytics and decision management solutions that connects, integrates and unifies functionality. This capability supports the integration of FICO® Customer Communication Services for coordinated, cross channel communications. The service supports real-time patient dialogue, immediate resolutions, timing text-messaging, and closed looped-learning to take medicine, refill or schedule follow-up labs or appointments tied to the requirements of the drug.
A custom analytic service, creation of a Medication Adherence Score establishes a direct connection between predictive analytics, action, and reaction—closing the learning loop on medication adherence.
Powerful prediction; fully-compliant to safeguard privacy
The data-driven predictive model assesses an individual’s likelihood of filling future prescriptions.
This can be modeled by therapeutic category, disease class, and brand or single-drug adherence models.
Analytic development and implementation is fully HIPPA-compliant for data privacy and provisions for safeguarding medical information.
Medication Adherence Score does not take an individual’s FICO® Score which measures credit risk into consideration.
Empower the team of care givers to make the right decisions
Medication non-adherence poses a real risk for patients and obstacle for the success rate of their healthcare providers.
A collaborative care team including physicians, pharmacists, nurses and the patient is crucial to establishing a medication adherence strategy to stay healthy and out of the hospital.
A common analytic, decision support and communications platform can serve as the guard rails for the best patient care tailored to their medical-adherence behavior and attributed level of risk for non-compliance.
Data-driven models to increase engagement
Data collected and used to create a predictive model depends on the patient performance to be measured.
From de-identified prescription records to third party ‘predictor’ data, FICO uses data sets to identify the best predictors of medication adherence and non-adherence.
The model is validated using patient populations to ensure strength and reliability.
Medication adherence is closely linked with positive clinical outcomes. As reported by the Center for Disease Control (CDC), one half of US patients stop taking their medications within one year of being prescribed. The FICO® Medication Ad...
The FICO® Score is the independent standard in credit risk scoring, trusted by lenders and investors for decades so they can say “yes” with confidence to more consumers. FICO’s enduring focus on innovation has facilitated access to credit ...
FICO Medication Adherence Score Article.pdf
Each year, it is estimated to result in around 125,000 premature deaths and cost the US health care system $290 billion. These social and economic costs are rising and likely to rise further unless current approaches to nonadherence are r...